Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2017 (2017), Article ID 3761292, 6 pages
https://doi.org/10.1155/2017/3761292
Clinical Study

Neoadjuvant Ifosfamide and Epirubicin in the Treatment of Malignant Peripheral Nerve Sheath Tumors

1Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, 660 South Euclid Ave., St. Louis, MO 63110, USA
2Siteman Cancer Center, St. Louis, MO 63110, USA
3Department of Radiation Oncology, Washington University School of Medicine, St. Louis, MO 63110, USA
4Department of Pathology and Immunology, Washington University School of Medicine, Campus Box 8118, 660 South Euclid Ave., St. Louis, MO 63110, USA

Correspondence should be addressed to Angela C. Hirbe

Received 16 February 2017; Accepted 13 April 2017; Published 4 May 2017

Academic Editor: Alessandro Gronchi

Copyright © 2017 Angela C. Hirbe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Angela C. Hirbe, Pippa F. Cosper, Sonika Dahiya, and Brian A. Van Tine, “Neoadjuvant Ifosfamide and Epirubicin in the Treatment of Malignant Peripheral Nerve Sheath Tumors,” Sarcoma, vol. 2017, Article ID 3761292, 6 pages, 2017. doi:10.1155/2017/3761292